These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 39335182)
1. Vitamin D in Cancer Prevention and Treatment: A Review of Epidemiological, Preclinical, and Cellular Studies. Dallavalasa S; Tulimilli SV; Bettada VG; Karnik M; Uthaiah CA; Anantharaju PG; Nataraj SM; Ramashetty R; Sukocheva OA; Tse E; Salimath PV; Madhunapantula SV Cancers (Basel); 2024 Sep; 16(18):. PubMed ID: 39335182 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Osborne JE; Hutchinson PE Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089 [TBL] [Abstract][Full Text] [Related]
4. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs. Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639 [TBL] [Abstract][Full Text] [Related]
5. Why vitamin D for cancer patients? Gandini S; Francesco F; Johanson H; Bonanni B; Testori A Ecancermedicalscience; 2009; 3():160. PubMed ID: 22276021 [TBL] [Abstract][Full Text] [Related]
6. The Relevance of Supplemental Vitamin D in Malignancies. Nica-Badea D; Udristioiu A Anticancer Agents Med Chem; 2021; 21(15):1942-1949. PubMed ID: 33438555 [TBL] [Abstract][Full Text] [Related]
7. Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis. Starska-Kowarska K Nutrients; 2023 May; 15(11):. PubMed ID: 37299554 [TBL] [Abstract][Full Text] [Related]
8. Assessment the effect of vitamin D supplementation on plasma vitamin D levels, inflammation, and oxidative stress biomarkers based on vitamin D receptor genetic variation in breast cancer survivors: a protocol for clinical trial. Kazemian E; Akbari ME; Moradi N; Gharibzadeh S; Amouzegar A; Rozek LS; Mondul AM; Khademolmele M; Zarins KR; Ghodoosi N; Shateri Z; Fallah S; Davoodi SH J Health Popul Nutr; 2021 Nov; 40(1):46. PubMed ID: 34727991 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment. Milczarek M; Filip-Psurska B; Swiętnicki W; Kutner A; Wietrzyk J Oncol Rep; 2014 Aug; 32(2):491-504. PubMed ID: 24919507 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D in Prostate Cancer. Ahn J; Park S; Zuniga B; Bera A; Song CS; Chatterjee B Vitam Horm; 2016; 100():321-55. PubMed ID: 26827958 [TBL] [Abstract][Full Text] [Related]
12. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis. Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo. Valrance ME; Brunet AH; Welsh J Endocrinology; 2007 Oct; 148(10):4887-94. PubMed ID: 17628009 [TBL] [Abstract][Full Text] [Related]
14. Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas. Pulito C; Terrenato I; Di Benedetto A; Korita E; Goeman F; Sacconi A; Biagioni F; Blandino G; Strano S; Muti P; Mottolese M; Falvo E PLoS One; 2015; 10(4):e0124894. PubMed ID: 25849303 [TBL] [Abstract][Full Text] [Related]
15. Anticancer activity of VDR-coregulator inhibitor PS121912. Sidhu PS; Teske K; Feleke B; Yuan NY; Guthrie ML; Fernstrum GB; Vyas ND; Han L; Preston J; Bogart JW; Silvaggi NR; Cook JM; Singh RK; Bikle DD; Arnold LA Cancer Chemother Pharmacol; 2014 Oct; 74(4):787-98. PubMed ID: 25107568 [TBL] [Abstract][Full Text] [Related]
16. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice. Zinser GM; McEleney K; Welsh J Mol Cell Endocrinol; 2003 Feb; 200(1-2):67-80. PubMed ID: 12644300 [TBL] [Abstract][Full Text] [Related]
17. Antiproliferative role of vitamin D and its analogs--a brief overview. Banerjee P; Chatterjee M Mol Cell Biochem; 2003 Nov; 253(1-2):247-54. PubMed ID: 14619976 [TBL] [Abstract][Full Text] [Related]
18. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells. Wietzke JA; Welsh J J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998 [TBL] [Abstract][Full Text] [Related]
19. Vitamin D, Cancer Risk, and Mortality. Tagliabue E; Raimondi S; Gandini S Adv Food Nutr Res; 2015; 75():1-52. PubMed ID: 26319903 [TBL] [Abstract][Full Text] [Related]
20. Dietary glycation compounds - implications for human health. Hellwig M; Diel P; Eisenbrand G; Grune T; Guth S; Henle T; Humpf HU; Joost HG; Marko D; Raupbach J; Roth A; Vieths S; Mally A Crit Rev Toxicol; 2024 Sep; 54(8):485-617. PubMed ID: 39150724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]